✦ LIBER ✦

PMS79 Mixed Treatment Comparison of Biologic Agents in Patients with Rheumatoid Arthritis Who Have responded Inadequately to Methotrexate Therapy in the United Kingdom

✍ Scribed by M. Lebmeier; L. Pericleous; P.C. Taylor; R. Christensen; P. Drost; G. Bergman; I. Eijgelshoven; P. Guyot

Book ID: 119310312
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 60 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS71 INDIRECT TREATMENT COMPARISON TO C

PMS71 INDIRECT TREATMENT COMPARISON TO COMPARE EFFICACY IN HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) SCORE FOR BIOLOGIC AGENTS WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ACTIVE DISEASE DESPITE METHOTREXATE THERAPY

✍ M Lebmeier; L Pericleous; P Guyot; H Baig; R Christensen; G Bergman; PC Taylor; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PMS37 THE COST-EFFECTIVENESS OF ABATACEP

PMS37 THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

✍ M Lebmeier; L Pericleous; P Drost; P Dequen; M Ouwens; G Bergman; H Baig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMS33 COST EFFECTIVENESS OF ABATACEPT IN

PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010

✍ F. Becerra Rojas; C. Benites Chacaltana; E.C. Aiello; C. Zingoni; G. Bergman; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Combination therapy with etanercept and

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

✍ Mark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Ric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective To determine the potential for additive or synergistic effects of combination therapy with the selective anti–tumor necrosis factor α agent etanercept and the anti–interleukin‐1 agent anakinra. ## Methods Two hundred forty‐four patients in whom rheumatoid arthritis (RA)